Review
Published on 05 Feb 2024
The effective combination therapies with irinotecan for colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1356708
- 2,732 views
- 1 citation
Type at least 3 characters
2,467 articles
Articles
Systematic Review
Published on 05 Feb 2024
A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1267763
- 1,014 views
Original Research
Published on 05 Feb 2024
Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1325447
- 1,546 views
Original Research
Published on 02 Feb 2024
Ceiba pentandra ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1337910
- 2,483 views
- 1 citation
Review
Published on 02 Feb 2024
The role of metal ions in the occurrence, progression, drug resistance, and biological characteristics of gastric cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1333543
- 2,629 views
Clinical Trial
Published on 01 Feb 2024
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1335054
- 1,577 views
Case Report
Published on 01 Feb 2024
Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic gastric mixed neuroendocrine-non-neuroendocrine tumor: a case report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1295134
- 1,358 views
Original Research
Published on 01 Feb 2024
Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1257941
- 1,865 views
Review
Published on 01 Feb 2024
Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1324140
- 2,521 views
- 1 citation
Original Research
Published on 31 Jan 2024
From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1329409
- 1,998 views
- 1 citation
Review
Published on 31 Jan 2024
Research progress on cuproptosis in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1290592
- 2,592 views
- 3 citations
Original Research
Published on 29 Jan 2024
Mechanisms underlying the therapeutic effects of cinobufagin in treating melanoma based on network pharmacology, single-cell RNA sequencing data, molecular docking, and molecular dynamics simulation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1315965
- 2,363 views
Review
Published on 25 Jan 2024
The application of peroxidase mimetic nanozymes in cancer diagnosis and therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1339580
- 1,606 views
- 1 citation
Original Research
Published on 25 Jan 2024
Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1332439
- 1,269 views
Original Research
Published on 25 Jan 2024
Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1315732
- 1,212 views
Review
Published on 24 Jan 2024
Hypoxia inducible factor-1É‘ as a potential therapeutic target for osteosarcoma metastasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1350187
- 1,427 views